Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)

R. Verma, H. Patel, H. Thuraisingam, G. Woltmann, P. Haldar (Leicester, United Kingdom)

Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Session: Immunological diagnosis of tuberculosis and latent tuberculosis infection
Session type: Oral Presentation
Number: 1991
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Verma, H. Patel, H. Thuraisingam, G. Woltmann, P. Haldar (Leicester, United Kingdom). Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB). Eur Respir J 2013; 42: Suppl. 57, 1991

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014


Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016


Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Diagnostic accuracy of the novel C-Tb skin test for LTBI, results from two phase III trials
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013